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DOI 10.1186/s12903-015-0026-6RESEARCH ARTICLE Open AccessPathological periodontal pockets are
associated with raised diastolic blood pressure
in obese adolescents
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Background: Obesity, a well-known risk factor for developing cardiovascular disease (CVD), is associated with
chronic periodontitis in adults. This cross-sectional pilot study on obese adolescents was designed to investigate
whether periodontal disease in terms of pathological periodontal pockets is associated with raised blood pressure
and other risk markers for CVD.
Methods: The study included 75 obese subjects between 12 to 18 years of age, mean 14.5. Subjects answered a
questionnaire regarding health, oral hygiene habits and sociodemographic factors. A clinical examination included Visible
Plaque Index (VPI %), Gingival inflammation (BOP %) and the occurrence of pathological pockets exceeding 4 mm
(PD≥ 4 mm). Blood serum were collected and analyzed. The systolic and diastolic blood pressures were registered.
Results: Adolescents with pathological periodontal pockets (PD≥ 4 mm; n = 14) had significantly higher BOP >25%
(P = 0.002), higher diastolic blood pressure (P = 0.008), higher levels of Interleukin (IL)-6 (P < 0.001), Leptin (P = 0.018),
Macrophage Chemoattractant Protein-1 (MCP-1) (P = 0.049) and thyroid stimulating hormone (TSH) (P = 0.004) in blood
serum compared with subjects without pathological periodontal pockets (PD≥ 4 mm; n = 61). The bivariate linear
regression analysis demonstrated that PD≥ 4 mm (P = 0.008) and systolic blood pressure (P < 0.001) were significantly
associated with the dependent variable “diastolic blood pressure”. The association between PD≥ 4 mm and diastolic
blood pressure remained significant (P = 0.006) even after adjusting for potential confounders BMI-sds, age, gender,
mother’s country of birth, BOP >25%, IL-6, IL-8, Leptin, MCP-1, TSH and total cholesterol in the multiple regression
analysis.
Conclusion: In conclusion, this study indicates an association between pathological periodontal pockets and diastolic
blood pressure in obese adolescents. The association was unaffected by other risk markers for cardiovascular events or
periodontal disease. The results call for collaboration between pediatric dentists and medical physicians in preventing
obesity development and its associated disorders.
Keywords: Obesity, Adolescents, Hypertension, Periodontal diseaseBackground
Obesity, a well-known risk factor for developing cardio-
vascular disease (CVD), is associated with chronic peri-
odontitis in adults and adolescents [1-4]. The main
underlying pathological pathway for CVD is atherosclerosis,
which arises from endothelial dysfunction driven by inflam-
matory processes. [5,6]. This dynamic and progressive* Correspondence: Cecilia.Zeigler@ki.se
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unless otherwise stated.inflammation is mediated by several inflammatory medi-
ators including Tumor necrosis factor alpha (TNF-α),
C-reactive protein (CRP), monocyte chemoattractant
protein-1 (MCP-1) and IL-1β, IL-6, and IL-8 [7,8]. These
inflammatory mediators are also connected with the
pathogenesis and inflammatory response of periodontal
disease [9-11] and they are affected in obese individuals
[12]. Periodontal disease is not a localized oral lesion, but
may contribute to a systemic immune response in pa-
tients [13]. The systemic inflammatory response accom-
panying periodontal disease has been proposed to haveThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Characteristics and oral hygiene habits of the
subjects with or without pathological periodontal pockets





Variables (n = 14) (n = 61) P-value1
Male/female ratio 8/6 34/27 0.925
Mean (SD) Mean (SD)
Age 14.5 (1.6) 14.5 (1.6) 0.998
Weight (kg) 105.0 (21.8) 108.5 (23.4) 0.855
Height (m) 1.71 (0.12) 1.70 (0.10) 0.637
BMI-sds2 5.3 (1.3) 5.7 (1.1) 0.209
n (%) n (%)
Chronic disease 3 (21) 17 (28) 0.629
Diabetes type 2 1 (7) 5 (8) 0.885
Thyroid dysfunctions 1 (7) 4 (7) 0.938
Daily use of prescribed
medication
3 (21) 21 (34) 0.354
Parents Country of birth
Mother - Sweden 7 (50) 35 (57)
- Not Sweden 7 (50) 26 (43) 0.497
Father - Sweden 6 (43) 35 (57)
- Not Sweden 8 (57) 26 (43) 0.260
Parents education3
Both parents ≤12år 11 (79) 40 (66)
One parent >12år 1 (7) 14 (23)
Both parents >12år 1 (7) 7 (11) 0.277
Tooth brushing
Daily morning 7 (50) 30 (49) 0.832
Daily evening 6 (43) 32 (52) 0.450
Daily flossing 1 (7) 2 (3) 0.948
1ONEWAY ANOVA and Chi2 used as statistical methods.
2According to Rolland-Cacherra [22].
3Education level of one parent was unknown to the participating subject.
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also be capable of inducing vascular inflammation, which
leads to endothelial dysfunction, an initial step for CVD
[14]. There are, as well, several studies presenting evi-
dence of the oral infection theory of atherogenesis [10].
Periodontal pathogens are able to cause transient bac-
teremia, invading the arterial wall and possibly lead to
vascular inflammation and atherosclerosis [14]. Interest-
ingly, periodontal therapy has been demonstrated, in
clinical interventions studies, to decrease levels of the
biomarkers CRP and IL-6 in serum as well as improving
endothelial function [14,15]. In addition, periodontal
treatment has been shown to reduce levels of cholesterol
and triglycerides both in adults [16,17] and children [18].
There is also emerging evidence that successful peri-
odontal treatment might help reduce blood pressure in
patients with hypertension [19]. As raised blood pressure
at a young age is a strong predictor for cardiovascular
mortality [20,21], it is interesting to test the hypothesis
whether there is any association between blood pressure
and early signs of periodontitis in adolescents. This
cross-sectional pilot study was therefore designed to in-
vestigate whether the occurrence of pathological peri-
odontal pockets might be associated with raised blood
pressure or other risk markers for CVD in obese
adolescents.
Methods
The present cross-sectional pilot study included 84
obese subjects who were recently referred to the Na-
tional Childhood Obesity Center, Karolinska University
Hospital, Huddinge, from their primary care giver or
school nurse. Subjects were consecutively referred to the
Division of Pediatric Dentistry, Karolinska Institutet for
oral examination as part of the medical investigation at
the National Childhood Obesity Center. Approximately
one subject per week underwent the registration proced-
ure and this study was conducted during an 18 month
period during 2006 and 2007. All subjects lived within
the hospitals catchment area and traveled less than one
hour to get to the Center. Body weight (kg) and height
(m) were determined and obesity was expressed as Body
Mass Index (BMI) (kg/m2) as well as by BMI adjusted
for age and gender (BMI-sds) [22]. The following exclu-
sion criteria were used: under 12 years of age, any anti-
biotic treatment during the last 3 months, ongoing
orthodontic treatment and/or subjects admitting to
smoking. After excluding subjects that did not meet the
criteria, 78 subjects remained. A further 3 subjects were
removed as sample sets were not complete. Finally 75
subjects remained (Table 1).
We certify that all applicable institutional and govern-
mental regulations concerning the ethical use of human
volunteers were followed during the research. The EthicsCommittee at Karolinska University Hospital Huddinge
approved the study and all subjects and parents gave
consent before participating. All subjects co-operated
satisfactorily during examinations, measurement and
sample-taking situations.
Questionnaire
All adolescents answered a questionnaire that covered
topics of their medical condition, medication, meal fre-
quency, oral hygiene habits, smoking habits, as well as
their parents’ education and country of birth. Parents’
country of birth was categorized into “born in Sweden”
or “born abroad”. The educational level of the parents
was stratified according to the years of schooling as ei-
ther ≤ 12 or > 12 years. Participants under 18 years were
assisted by a parent when answering the questionnaire.
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Dental plaque on tooth surfaces was recorded when
clearly visible and expressed using the Visible Plaque
Index (VPI) [23]. Gingival inflammation was based on
Bleeding on Probing (BOP) [24]. Both VPI and BOP was
recorded at six sites on each tooth (wisdom teeth ex-
cluded). The proportion of surfaces (%) with visible den-
tal plaque and gingival inflammation, respectively, was
calculated for each subject.
Pocket depth (mm) was recorded by using a graded peri-
odontal probe (LM-instruments OY, Parainen, Finland)
and measured to the nearest mm. The occurrence of
pathological periodontal pockets was classified when the
subject exhibited one or more sites with a pocket depth
of ≥ 4 mm. Erupting and deciduous teeth were excluded.
Supragingival calculus was recorded on all teeth as
present when clearly visible. Subgingival calculus was re-
corded on the radiographs taken as well as clinically
after probing the gingival sulcus. The oral clinical re-
cording was performed by one of the authors (CZ).
Systolic and diastolic blood pressure was measured in
the sitting position with a mercury sphygmomanometer
with a standard pressure cuff of the correct size on the
left arm. Blood pressures were measured in duplicates. A
third measurement was taken if the two readings dif-
fered more than 5 mm Hg and the mean of the two clos-
est readings was used. The same experienced nurse
practitioner performed all measurements.
Blood samples were taken after an overnight fast start-
ing at midnight. Fasting was confirmed by the child and
parent before collecting blood. Blood samples for High
density lipoprotein (HDL) were analyzed immediately.
Remaining samples were kept frozen in-80°C until ana-
lyzed. HDL, TSH and CRP-sensitivity analyzes were per-
formed at a certified laboratory (Department of Clinical
Chemistry, Karolinska University Hospital). IL-1β, IL-6,
IL-8, MCP-1 and Leptin were analyzed using commer-
cially available Luminex kits (Linco Research, Inc.,
Missouri, USA). TNF-α levels were measured using Bio-
Plex cytokine assay (Bio-Rad laboratories, California, USA).
Statistics
For analyzing the data, frequency tables, cross tables,
ONEWAY ANOVA, Chi-square, linear regression were
used by SPSS version 21.0 (SPSS, Chicago, IL, USA). Bi-
variate analyses were carried out between the dependent
variable diastolic blood pressure or systolic blood pres-
sure and the independent variables by applying a linear
regression model. In the multiple linear regression ana-
lysis with diastolic blood pressure as dependent variable,
the independent variable PD ≥ 4 mm was adjusted for
potential confounders (BMI-sds, age, gender, mother’s
country of birth, BOP >25%, IL-6, IL-8, Leptin, MCP-1,
TSH and total cholesterol).Confidence Interval 95% was calculated. Level of sig-
nificance was accepted at P-values less than 0.05. In case
of biochemical variables, the Bonferroni test adjusted for
intra correlations between the biomedical variables and
a P-value of <0.01 was required to declare significance
to avoid chance of mass significance.
Results
Of the subjects included in this study (n = 75), 14 dis-
played pathological periodontal pockets (PD ≥ 4 mm)
and 61 were without pathological periodontal pockets
(PD < 4 mm, n = 61). There was no significant difference
between adolescents with and without PD ≥ 4 mm in
regards to age, gender, BMI-sds, tooth brushing habits,
sociodemographic factors, medical history or visible
plaque index (VPI > 25%) (Table 1). Adolescents with
PD ≥ 4 mm had significantly higher presence of BOP > 25%,
higher diastolic blood pressure (P = 0.008) and signifi-
cantly higher levels of IL-6 (P < 0.001), Leptin (P = 0.018),
MCP-1 (P = 0.049) and TSH (P = 0.004) in blood serum
(Table 2). Presence of calculus, IL-1β, IL-8, TNF-α, total
cholesterol, LDL/HDL quotient, Hba1c, or CRP levels did
not differ significantly between the two groups and neither
did systolic blood pressure (Table 2). Other blood markers
were tested (Adiponectin, PAI-1, Insulin, Glucose, Alat,
Creatinine, Apolipo A1, Apolipo B, fP-TG, Urea, IGF-1)
and no significant differences were demonstrated between
the groups (data not shown).
Subjects with PD ≥ 4 mm had an average diastolic blood
pressure of 74 mmHg whilst subjects without PD ≥ 4 mm
had average diastolic blood pressure of 67 mmHg.
In a bivariate linear regression analysis with diastolic
blood pressure as dependent variable, following variables
were significantly associated: PD ≥ 4 mm (P = 0.008) and
systolic blood pressure (P < 0.001) (Table 3). As demon-
strated in Table 4, PD ≥ 4 mm remained significantly
(P = 0.006) associated with diastolic blood pressure even
after adjusting for BMI-sds, age, gender, mother’s coun-
try of birth, BOP >25%, IL-6, IL-8, Leptin, MCP-1, TSH
and total cholesterol in a multiple linear regression
analysis.
In a bivariate linear regression analysis with systolic
blood pressure as dependent variable, diastolic blood pres-
sure (P > 0.001) as well as serum level of TSH (P = 0.039)
showed significant association (data not shown).
Discussion
The main finding in this study demonstrates an associ-
ation between periodontal disease in terms of patho-
logical periodontal pockets and diastolic blood pressure
in obese adolescents. Obese subjects with pathological
periodontal pockets had significantly higher diastolic
blood pressure (74 mmHg) compared with periodontally
healthy obese adolescents (67 mmHg). Pediatric subjects
Table 2 Clinical and biomedical variables in blood serum
of the subjects with or without pathological periodontal





(n = 14) (n = 61)
Variables Number (%) Number (%) P-value1
Presence of dental calculus
Supragingival 8 (57) 22 (36) 0.151
Subgingival 4 (29) 10 (16) 0.586
VPI
0-25% 8(57) 47 (77)
> 25% 6 (43) 14 (23) 0.132
BOP
0-25% 5 (36) 47 (77)
> 25% 9 (64) 1 (23) 0.002
Mean (SD) Mean (SD)
Adiponectin (μg/ml) 13.5 (74.3) 12.3 (802) 0.641
PAI-1 Tot (ng/ml) 42.8 (19.2) 944 (6635) 0.642
IL-1β (pg/ml) 0.8 (0.8) 1.1 (4.1) 0.819
IL-6 (pg/ml) 37.5 (44.9) 10.5 (11.3) <0.001
IL-8 (pg/ml) 15.2 (7.7) 33.9 (106.8) 0.548
Leptin (ng/ml) 66.3 (54,1) 41.2 (23.0) 0.018
TNF-α (pg/ml) 6.9 (2.5) 6.8 (3.1) 0.848
MCP-1 (pg/ml) 256 (104) 464 (352) 0.049
Total cholesterol (mmol/l) 3.9 (0.7) 4.0 (0.7) 0.645
LDL/HDL quotient 2.1 (1.0) 2.2 (0.7) 0.404
Hba1c (mmol/mol) 4.5 (0.4) 4.6 (0.4) 0.182
CRP (mg/l) 2.6 (2.7) 4.7 (4.1) 0.071
TSH (mlU/l) 3.9 (3.0) 2.5 (1.1) 0.004
Blood pressure (mmHg)
-Systolic 119 (9) 116 (9) 0.294
-Diastolic 74 (5) 67 (7) 0.008
Insulin resistance Bergman
-Si (×10−4/min/pM) 1.9 (1.3) 1.5 (1.4) 0.313
-Air (pM) 1930 (1782) 3107 (3692) 0.254
1ONEWAY ANOVA as statistical method.
Table 3 Bivariate linear regression analysis with diastolic




Age 0.09 0.59 0.481 −0.76 – 1.60
Gender −0.13 1.87 0.303 −5.66 – 1.80
Mother country of
birth (not Sweden)
0.42 3.16 0.056 −0.15 – 12.48
Father country of
birth (not Sweden)
−0.34 3.16 0.116 −11.37 – 1.29
BMI-sds 0.07 0.85 0.593 −1.25 – 2.15
PD ≥4 mm 0.33 0.98 0.008 1.69 – 10-69
Presence of dental calculus
Supragingival −0.02 1.92 0.901 −4.07 – 3.59
Subgingival 0.05 1.17 0.669 −1.8 – 2.84
VPI (>25)% 0.02 2.11 0.861 −3.85 – 4.59
BOP (>25%) 0.06 2.07 0.662 −3.23 – 5.05
IL-1β (pg/ml) −0.16 0.29 0.301 −0.89 – 0.28
IL-6 (pg/ml) −0.01 0.04 0.993 −0.08 – 0.09
IL-8 (pg/ml) −0.25 0.01 0.072 −0.04 – 0.01
Leptin (ng/ml) 0.08 0.01 0.581 −0.01 – 0.01
TNF-α (pg/ml) 0.04 0.33 0.793 −0.58 – 0.75
MCP-1 (pg/ml) −0.09 0.01 0.491 −0.01 – 0.01
Total cholesterol
(mmol/l)
−0.23 1.25 0.065 −4.87 – 0.15
LDL/HDL quotient −0.10 1.42 0.460 −3.90 – 1.79
Hba1c (mmol/mol) −0.03 2.15 0.823 −4.78 – 3.81
CRP (mg/l) −0.012 0.23 0.924 −0.49 – 0.45
TSH (mlU/l) −0.01 0.54 0.960 −1.10 – 1.05
Systolic blood
pressure (mmHg)
0.44 0.09 <0.001 0.16 – 0.53
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and diastolic blood pressure than their normal weight
counterparts [24,25]. The average diastolic blood pres-
sure for obese adolescents is reported to vary from 62
mmHg to 70 mmHg [26,27] with a frequency of prehy-
pertension of approximately 20% [28,29]. However, there
is still an on-going debate on how and when to diagnose
children and adolescents as pre-hypertensive, hyperten-
sive or normal [30-32]. Considering this lack of agree-
ment and the limited number of participants included in
this study we used blood pressure as a continuousvariable in the statistical analysis rather than dividing the
subjects into groups based on level of blood pressure.
Consequently, we report our findings as raised diastolic
blood pressure, instead of prehypertension or patho-
logical hypertension.
In the current study we used one-time blood pressure
measurement in a resting position which is an accept-
able screening method [33]. However, most recommend
that to diagnose a child or adolescent with hypertension,
a 24 hour evaluation is necessary. [34,35]. Based on the
blood pressure method used, one has to consider that
other stress factors such as travel time and transporta-
tion method might have affected blood pressure levels.
The endpoint of inflammatory periodontal disease in-
cludes alveolar bone resorption and subsequently loss of
teeth. Subjects in this study are young and the effect of
chronic inflammation on periodontal tissue needs longer
exposure time until alveolar bone loss is possible to de-
tect on the radiographs. Therefore, we used pathological
Table 4 Multiple linear regression analysis with diastolic




PD ≥ 4 mm-unadjusted 0.33 0.98 0.008 1.69 – 10-69
-Adjusted for
BMI-sds 0.36 2.29 0.005 11.29 – 2.11
Age 0.33 2.26 0.008 1.69 – 10.73
Gender 0.33 2.26 0.009 1.59 – 10.61
Mother’s country of birth 0.32 2.38 0.013 1.36 – 10.87
BOP >25% 0.35 2.39 0.008 1.74 – 11.31
Leptin (ng/ml) 0.43 2.60 0.005 2.48 – 12.93
MCP-1 (pg/ml) 0.37 2.53 0.009 1.85 – 11.99
TSH (mlU/l) 0.37 2.37 0.005 2.17 – 11.67
IL-6 (pg/ml) 0.46 2.77 0.002 3.49 – 14.60
IL-8 (pg/ml) 0.35 2.41 0.008 0.81 – 11.47
Total cholesterol (mmol/l) 0.31 2.23 0.012 1.31 – 10.25
PD ≥ 4 mm adjusted for
BMI-sds, age, gender,
mother’s country of birth,
BOP > 25%, leptin, MCP-1,
TSH, IL-6, IL-8 and cholesterol
0.48 3.18 0.007 2.68 – 15.67
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used as a periodontal risk indicator in young subjects [1]
in the statistical analysis. To investigate if indeed the sys-
temic inflammatory response accompanying periodontal
disease could be part of the mechanism of atheroscler-
osis and its cardiovascular ill-effects [36,37], we used
diastolic blood pressure as the dependent variable in the
linear regression model. Of the variables studied, only
PD ≥4 mm and systolic blood pressure demonstrated a
significant association in the bivariate linear regression
model (Table 3). We further tested the association be-
tween diastolic blood pressure and PD ≥4 mm in a mul-
tiple linear regression model (Table 4). Variables known
to have effect on blood pressure in adolescents: BMI-
sds, gender and age [34] were entered into the model.
Since mother’s country of birth, IL-8 and Cholesterol
were near significant in the bivariate analysis these vari-
ables were, as well, entered into the model. The cytokine
IL-8 is, as well, known to be involved in the pathogen-
esis of hypertension [8]. As shown in Table 2 BOP >25%,
IL-6, Leptin, TSH and MCP-1 varied significantly be-
tween the subjects with or without PD ≥4 mm, therefor
they were, as well, entered into the model. The associ-
ation between PD ≥4 mm and diastolic blood pressure
was not affected by any of the potential confounders en-
tered into the model (Table 4). The significant higher
level of IL-6, TSH and Leptin in serum in the subjects
with PD ≥4 mm (Table 2) further support the notion
that, in obese subjects, periodontal disease is part of an
systemic inflammation that might, in the long run, leadto atherosclerosis and CVD [38,39]. In addition, it has
recently been reported that an increase in leptin levels in
diet-induced obese rodents drives an increase in blood
pressure, an effect that was not seen in animals deficient
of leptin or leptin receptors [40]. Further support comes
from clinical studies demonstrating that periodontal
treatment lowers the levels of both IL-6 and Leptin in
serum [41] and thereby decreases the burden of systemic
inflammation.
TSH has not previously been connected to periodontal
disease, but is reported to be enhanced in serum in
obese subjects [42]. In this study, the subjects without
PD ≥4 mm had TSH levels corresponding to average
levels in healthy individuals, whilst the subjects with PD
≥4 mm had relatively higher levels. Interestingly, it has
been reported that increases in TSH levels are associated
with increases in both systolic and diastolic blood pres-
sure as well as other cardiovascular risk factors [43-45].
Our finding that there is an association between PD
≥4 mm and diastolic blood pressure is compatible with
the finding in a similar age group that overweight/obese
adolescents had significantly higher blood pressure and
more gingival inflammation than their normal weight
counterparts [24]. However, the authors did not report if
there was a direct association between periodontal in-
flammation and blood pressure. In addition, our finding
regarding the association between PD ≥4 mm and raised
diastolic blood pressure is well compatible with the view
that adolescents positive for 3 or more variables, associ-
ated with metabolic syndrome, are more likely to display
gingival inflammation than healthy individuals [46].
Interestingly, the current epidemiological data also indi-
cate that there is an association between periodontal dis-
ease and hypertension in adults as well [14,47].
Perpending the finding, that diastolic blood pressure
at 18 years of age seems to be a stronger predictor for
cardiovascular mortality than systolic blood pressure
[20], it is interesting to consider whether the occurrence
of PD ≥4 mm in children with obesity might be an early
marker for future cardiovascular events.
This pilot study has, however, several limitations. Since
no normal weight participants are included, the associ-
ation between periodontal disease and raised diastolic
blood pressure might be specific for the obese condition.
We did not register the duration of obesity of the subjects
which probably also, in addition to the severity of obesity,
is of importance when looking at the association between
periodontal risk factors and blood pressure. Since this
study has a cross sectional design, a longitudinal study is
needed before any conclusions can be drawn.
Conclusion
This study indicates an association between pathological
periodontal pockets and diastolic blood pressure in obese
Zeigler et al. BMC Oral Health  (2015) 15:41 Page 6 of 7adolescents. The association was unaffected by other risk
markers for cardiovascular events or periodontal disease.
The results call for collaboration between pediatric den-
tists and medical physicians in preventing obesity develop-
ment and its associated disorders.
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